Euda Health Holdings Stock Net Income
| EUDA Stock | 1.55 0.04 2.52% |
As of the 27th of January, EUDA Health shows the Mean Deviation of 7.87, variance of 165.14, and Standard Deviation of 12.85. EUDA Health Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
EUDA Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 11.7648 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -15.9 M | -16.7 M | |
| Net Loss | -22.4 M | -21.3 M | |
| Net Loss | -15.8 M | -16.6 M | |
| Net Loss | (0.54) | (0.57) | |
| Net Income Per E B T | 0.78 | 0.69 |
EUDA | Net Income | Build AI portfolio with EUDA Stock |
Latest EUDA Health's Net Income Growth Pattern
Below is the plot of the Net Income of EUDA Health Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in EUDA Health Holdings financial statement analysis. It represents the amount of money remaining after all of EUDA Health Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is EUDA Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (17.6 M) | 10 Years Trend |
|
Net Income |
| Timeline |
EUDA Net Income Regression Statistics
| Arithmetic Mean | (4,459,889) | |
| Coefficient Of Variation | (179.06) | |
| Mean Deviation | 6,625,273 | |
| Median | 175,575 | |
| Standard Deviation | 7,986,050 | |
| Sample Variance | 63.8T | |
| Range | 25.7M | |
| R-Value | (0.71) | |
| Mean Square Error | 33.8T | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | (1,122,361) | |
| Total Sum of Squares | 1020.4T |
EUDA Net Income History
Other Fundumenentals of EUDA Health Holdings
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
EUDA Health Net Income component correlations
EUDA Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for EUDA Health is extremely important. It helps to project a fair market value of EUDA Stock properly, considering its historical fundamentals such as Net Income. Since EUDA Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EUDA Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EUDA Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
EUDA Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to EUDA Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of EUDA Health.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in EUDA Health on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding EUDA Health Holdings or generate 0.0% return on investment in EUDA Health over 90 days. EUDA Health is related to or competes with American Well, Hyperfine, ZEN Graphene, Quince Therapeutics, Fonar, Precision BioSciences, and Fractyl Health. EUDA Health is entity of United States. It is traded as Stock on NASDAQ exchange. More
EUDA Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure EUDA Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess EUDA Health Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 83.79 | |||
| Value At Risk | (15.69) | |||
| Potential Upside | 13.58 |
EUDA Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for EUDA Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as EUDA Health's standard deviation. In reality, there are many statistical measures that can use EUDA Health historical prices to predict the future EUDA Health's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (1.56) | |||
| Treynor Ratio | 0.1402 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of EUDA Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
EUDA Health January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.1502 | |||
| Mean Deviation | 7.87 | |||
| Coefficient Of Variation | (4,117) | |||
| Standard Deviation | 12.85 | |||
| Variance | 165.14 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (1.56) | |||
| Treynor Ratio | 0.1402 | |||
| Maximum Drawdown | 83.79 | |||
| Value At Risk | (15.69) | |||
| Potential Upside | 13.58 | |||
| Skewness | 0.3086 | |||
| Kurtosis | 6.48 |
EUDA Health Holdings Backtested Returns
EUDA Health appears to be abnormally volatile, given 3 months investment horizon. EUDA Health Holdings secures Sharpe Ratio (or Efficiency) of 0.0282, which denotes the company had a 0.0282 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for EUDA Health Holdings, which you can use to evaluate the volatility of the firm. Please utilize EUDA Health's Variance of 165.14, mean deviation of 7.87, and Standard Deviation of 12.85 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, EUDA Health holds a performance score of 2. The firm shows a Beta (market volatility) of -2.3, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning EUDA Health are expected to decrease by larger amounts. On the other hand, during market turmoil, EUDA Health is expected to outperform it. Please check EUDA Health's treynor ratio, skewness, and the relationship between the jensen alpha and value at risk , to make a quick decision on whether EUDA Health's price patterns will revert.
Auto-correlation | -0.34 |
Poor reverse predictability
EUDA Health Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between EUDA Health time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of EUDA Health Holdings price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current EUDA Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.15 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
EUDA Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, EUDA Health Holdings reported net income of (17.6 Million). This is 105.16% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.08% higher than that of the company.
EUDA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EUDA Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics of similar companies.EUDA Health is currently under evaluation in net income category among its peers.
EUDA Health Institutional Holders
Institutional Holdings refers to the ownership stake in EUDA Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EUDA Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EUDA Health's value.| Shares | Hudson Bay Capital Management Lp | 2025-06-30 | 796.1 K | Citadel Advisors Llc | 2025-06-30 | 28.3 K | Geode Capital Management, Llc | 2025-06-30 | 16 K | Ubs Group Ag | 2025-06-30 | 4.6 K | Xtx Topco Ltd | 2025-03-31 | 0.0 |
EUDA Fundamentals
| Return On Asset | -0.64 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | (0.37) % | ||||
| Current Valuation | 60.71 M | ||||
| Shares Outstanding | 37.81 M | ||||
| Shares Owned By Insiders | 49.60 % | ||||
| Shares Owned By Institutions | 1.01 % | ||||
| Number Of Shares Shorted | 203.63 K | ||||
| Price To Sales | 10.26 X | ||||
| Revenue | 4.01 M | ||||
| Gross Profit | 1.16 M | ||||
| EBITDA | (17.42 M) | ||||
| Net Income | (17.6 M) | ||||
| Total Debt | 1.27 M | ||||
| Book Value Per Share | (0.10) X | ||||
| Cash Flow From Operations | (2.03 M) | ||||
| Short Ratio | 0.34 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 117 | ||||
| Beta | -0.13 | ||||
| Market Capitalization | 52.93 M | ||||
| Total Asset | 1.73 M | ||||
| Retained Earnings | (50.1 M) | ||||
| Working Capital | (3.38 M) | ||||
| Net Asset | 1.73 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Check out EUDA Health Piotroski F Score and EUDA Health Altman Z Score analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.